PKR Inhibitor,
PKR-IN-C16,
608512-97-6,
(Z)-8-((1H-Imidazol-4-yl)methylene)-6H-thiazolo[5,4-e]indol-7(8H)-one,
AC1O5VPR,
ASN 11124542,
RNA-Dependent Protein Kinase Inhibitor,
CHEMBL235641,
GTPL6026,
SCHEMBL9886520,
HMS3229I15,
ZINC4908387,
HY-13977A,
AKOS025147356,
CCG-206776,
NCGC00387501-01,
RT-015072,
CS-0009102,
A13538,
Q5007568,
Imidazolo-oxindole PKR inhibitor C16, >=98% (HPLC),
(8Z)-8-(1H-imidazol-5-ylmethylidene)-6H,7H,8H-[1,3]thiazolo[5,4-e]indol-7-one,
(Z)-8-((1H-imidazol-5-yl)methylene)-6,8-dihydro-7H-thiazolo[5,4-e]indol-7-one,
6,8-Dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo[2,3-g]benzothiazol-7-one,
PKRi,
C16 PKR inhibitor,
EIF2AK2 Inhibitor I,
D0C1DQ,
Imidazolo-oxindole PKR inhibitor C16,
CID6490494,
GW 506033X,
ASN-11124542,
8- -6,8-DIHYDRO-THIAZOLO[5,4-E]INDOL-7-ONE,
C000617853,
Double-stranded RNA-activated Protein Kinase Inhibitor I,
Double-stranded RNA-dependent Protein Kinase Inhibitor C16,
8-(1H-IMIDAZOL-4-YLMETHYLENE)-6,8-DIHYDRO-THIAZOLO[5,4-E]INDOL-7-ONE,
C16,
(8z)-8-(1h-Imidazol-5-Ylmethylidene)-6,8-Dihydro-7h-[1,3]thiazolo[5,4-E]indol-7-One,
(8Z)-8-(1H-imidazol-5-ylmethylidene)-6H-pyrrolo[2,3-g][1,3]benzothiazol-7-one,
6,8-dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo(2,3-g)benzothiazol-7-one,
6,8-dihydro-8-1H-imidazol-5-ylmethylene)-7H-pyrrolo(2,3-g)benzothiazol-7-one),
7H-Pyrrolo[2,3-g]benzothiazol-7-one, 6,8-dihydro-8-(1H-imidazol-5-ylmethylene)-, (8Z)-,
1159885-47-8,